ArticlePharmacoEconomics2019
Correction to: Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review.
Dongzhe Hong et al.PubMed ↗Publisher ↗
No numbers read from the abstract.